Trial Profile
The BOKITO-1B Study: Tenofovir DF Bone and Kidney Toxicity. Pharmacology in HBV monoinfected patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Nov 2012
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Acronyms BOKITO-1B
- 12 Nov 2012 New trial record